Pounding the Pavement for a Cause that Hits Home

As the Director of the Adolescent and Young Adults (AYA) Lymphoma Program, Dr. Lisa Roth has a unique ability to empathize with her patients. Three years ago, Dr. Roth herself was diagnosed with lymphoma. As an oncologist, she was used to confronting cancer every day, but never on such a deeply personal level. Not unlike many of her patients, she went from being young and healthy to facing a life-threatening illness with no warning.

After successfully undergoing chemotherapy, Dr. Roth’s lymphoma was in remission and she made running part of her recovery process. Six months after finishing cancer treatment, she ran her first race in the New York Road Runners Mini 10K.

LR RR
(L-R) Dr. Lisa Roth and her son Zachary with Mana and Sammy after the 2016 Mini 10K.

Last weekend Dr. Roth returned to run the 2016 Mini 10K, but this year she was running for one of her precocious pediatric patients.

For Sammy, a six-year-old who has been battling leukemia for almost two years, his days are filled with not only play dates, ninjas and superheroes, but also routine visits to Weill Cornell and NewYork Presbyterian Hospital for chemotherapy and other procedures related to his diagnosis.

“Sammy and his family are a true inspiration,” says Roth. As part of “Team Sammy” Dr. Roth, along with Sammy’s mom Mana and a team of 12 people, ran the 10K and raised nearly $18,000 for the Leukemia and Lymphoma Society, proving you don’t need superpowers to make a difference in the fight against blood cancer.

For Dr. Roth, it’s also personal. “This was my first race as a new mom. I owe my life and opportunity to be a mom to research funded by groups like the Leukemia & Lymphoma Society,” says Roth.

Learn more about Dr. Roth and Team Sammy, as they were recently featured on the New York Road Runners website.

Author: lymphomaprogram

Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.

Post a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s